The landscape of dementia prognosis has progressed radically with the arrival of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-based checks that could detect Alzheimer's pathology many years before signs or symptoms emerge. Though these technological improvements signify extraordinary progress in being familiar with neurodegenerative conditions, they https://johnh431pbl3.vidublog.com/profile